Table 2.

Sample characteristics

Sample characteristic	Value
Total number of analyzed samples	152
Obtained during PIPAC 1 (“untreated”)	53 (34.9 %)
Obtained during PIPAC ≥2 (“treated”)	99 (65.1 %)
Histologically assessed as
Tumor	136 (89.5 %)
With concurrent ascites	88 (64.7 %)
Without concurrent ascites	48 (35.3 %)
Tumor-free	16 (10.5 %)